Unique Plan Description: levalbuterol (Xopenex)-acetylcysteine (Mucomyst) 20 percent
Plan Selection Display: levalbuterol (Xopenex)-acetylcysteine (Mucomyst) 20 percent
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2012-02-29 08:01:27
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2023-06-06 12:47:45
Available at all facilities: No

levalbuterol (Xopenex)-acetylcysteine (Mucomyst) 2
Medications
	levalbuterol 1.25 mg/3 ml inhalation solution
		3 mL, Solution-Nebulization, NEBULIZED, Q8H
	acetylcysteine 20% inhalation soln
		1 mL, Soln, NEBULIZED, Q8H

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase